Post

New research · Ophthalmology
Korean journal of ophthalmology : KJO · 2d
Cohort studyKorean journal of ophthalmology : KJO · 2026

Real-World Treatment Outcome of Intravitreal Ranibizumab and Aflibercept in Pseudophakic Eyes with Neovascular Age-Related Macular Degeneration.

Seungmin Choi, Jinsoo Kim, Min Seon Park … Bum-Joo Cho
Read paper
OphthalmologyCohort study

Vision improved most 3 months after starting anti-VEGF injections for wet macular degeneration.

Real-World Treatment Outcome of Intravitreal Ranibizumab and Aflibercept in Pseudophakic Eyes with Neovascular Age-Related Macular Degeneration.

Seungmin Choi … Bum-Joo Cho
Korean journal of ophthalmology : KJO · 2026
Purpose

To evaluate the long-term real-world treatment outcome of intravitreal ranibizumab and aflibercept injections in pseudophakic eyes with neovascular age-related macular degeneration (nAMD), independently of the effect of cataract progression.

Methods

Medical records of pseudophakic patients with nAMD who were treatment-naïve, underwent intravitreal injection of ranibizumab or aflibercept between March 2010 and August 2023, and then were followed up for at least 1 year were retrospectively reviewed.

n = 93 patients
Results

vision-quality reading check improved most three months after starting treatment

Baseline
51letter
3 months
57.4letter
1 year
53letter
2 years
52.9letter
More results

In contrast, the mean central subfield thickness significantly decreased from 351.2 ± 114.6 μm to 230.7 ± 93.5 μm at 3 months, followed by a mild increase to 271.8 ± 117.1 μm at 1 year, and remained stable at 271.4 ± 160.5 μm at 2 years.

Thereafter, central subfield thickness gradually decreased reaching 251.7 ± 125.2 μm by the fifth year.

More results

There were no statistically significant differences in visual acuity or central subfield thickness between the ranibizumab and aflibercept groups throughout the period.

“
Conclusion

For eyes with sustained long-term follow-up, the visual outcomes of pseudophakic patients with nAMD, unaffected by cataract progression, were maintained at a good level above baseline over 4 years after intravitreal injection in the real-world, while central subfield thickness decreased consistently from 2 to 5 years after treatment.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment